The page is the record's research on the issuer — no analyst, no rating, no view. # ASTRAZENECA PLC (NYSE: AZN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is ASTRAZENECA PLC, listed on NYSE under ticker AZN. Its ISIN is USG0593M1074 and its LEI is not on the record. Its security type is recorded as non-operating entity type (other), and its segment is not on the record. Its sector is 2834 Pharmaceutical Preparations and its jurisdiction is the United Kingdom. Its status is listed, not halted. ## The disclosure read The record holds 140 filings in the twelve months from 2025-11-08 to 2026-11-08, across 90 filing days. Of these, 112 are results, 14 are regulatory filings, 8 are directors' dealings, 4 are halt or suspension notices, and 2 are prospectuses. The median gap between filing days is 3 days. The latest filing is a results filing dated 2026-11-02, 6 days before the record date. The NYSE median cadence gap is 6.0 days across 3256 issuers, with a median of 64.0 filings and a median latency of 4.0 days. The sector median cadence gap is 6.0 days across 526 issuers, with a median of 63.0 filings and a median latency of 4.0 days. ## Auditor The auditor is not on the record, because the latest annual report cover carries no auditor name tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds four delisting lines, dated 2025-11-14, 2026-01-30, 2026-04-08 and 2026-05-28. It holds six listing lines, dated 2026-01-22 (four lines), 2026-03-03 and 2026-03-04. No name change is on the record. No domicile change is on the record, as EDGAR states no dated change of state of incorporation on a filing line. No segment move is on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years for this issuer for 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0000901832.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/AZN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/AZN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/AZN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp